Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Cash from Financing Activities: 2012-2024

Historic Cash from Financing Activities for Tvardi Therapeutics (TVRD) over the last 13 years, with Dec 2024 value amounting to -$3.6 million.

  • Tvardi Therapeutics' Cash from Financing Activities rose 120.48% to $183,000 in Q4 2017 from the same period last year, while for Dec 2017 it was $87.9 million, marking a year-over-year increase of 16.18%. This contributed to the annual value of -$3.6 million for FY2024, which is 109.45% down from last year.
  • According to the latest figures from FY2024, Tvardi Therapeutics' Cash from Financing Activities is -$3.6 million, which was down 109.45% from $38.2 million recorded in FY2023.
  • In the past 5 years, Tvardi Therapeutics' Cash from Financing Activities registered a high of $46.6 million during FY2021, and its lowest value of -$3.6 million during FY2024.
  • In the last 3 years, Tvardi Therapeutics' Cash from Financing Activities had a median value of $311,000 in 2022 and averaged $11.6 million.
  • As far as peak fluctuations go, Tvardi Therapeutics' Cash from Financing Activities soared by 12,167.20% in 2023, and later tumbled by 109.45% in 2024.
  • Yearly analysis of 5 years shows Tvardi Therapeutics' Cash from Financing Activities stood at $39.1 million in 2020, then climbed by 19.08% to $46.6 million in 2021, then plummeted by 99.33% to $311,000 in 2022, then skyrocketed by 12,167.20% to $38.2 million in 2023, then plummeted by 109.45% to -$3.6 million in 2024.